BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24461890)

  • 21. Crizotinib in the treatment of non-small-cell lung cancer.
    Forde PM; Rudin CM
    Expert Opin Pharmacother; 2012 Jun; 13(8):1195-201. PubMed ID: 22594847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of the anaplastic lymphoma kinase.
    Mologni L
    Expert Opin Investig Drugs; 2012 Jul; 21(7):985-94. PubMed ID: 22612599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer.
    Kijima T; Takeuchi K; Tetsumoto S; Shimada K; Takahashi R; Hirata H; Nagatomo I; Hoshino S; Takeda Y; Kida H; Goya S; Tachibana I; Kawase I
    Cancer Sci; 2011 Aug; 102(8):1602-4. PubMed ID: 21767331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives.
    Lee JA; Bubendorf L; Stahel R; Peters S
    Expert Rev Anticancer Ther; 2013 May; 13(5):625-36. PubMed ID: 23617353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for lung cancer: what is the evidence?
    Mahon SM
    Clin J Oncol Nurs; 2004 Apr; 8(2):188-9. PubMed ID: 15108420
    [No Abstract]   [Full Text] [Related]  

  • 26. Low-dose spiral CT for lung cancer screening.
    Meziane M; Decamp M
    Cleve Clin J Med; 2001 Jan; 68(1):84. PubMed ID: 11204370
    [No Abstract]   [Full Text] [Related]  

  • 27. Lung cancer screening in Australia: progress or procrastination?
    Brims F; McWilliams A; Fong K
    Med J Aust; 2016 Jan; 204(1):4-5. PubMed ID: 26763803
    [No Abstract]   [Full Text] [Related]  

  • 28. Considerations in the development of lung cancer screening tools.
    Mulshine JL; Tockman MS; Smart CR
    J Natl Cancer Inst; 1989 Jun; 81(12):900-6. PubMed ID: 2659802
    [No Abstract]   [Full Text] [Related]  

  • 29. Future Perspectives in Cancer Screening and Early Detection.
    Coovadia A; Eggert JA
    Semin Oncol Nurs; 2017 May; 33(2):219-222. PubMed ID: 28359654
    [No Abstract]   [Full Text] [Related]  

  • 30. Lung Cancer Screening with CT: A Few Steps on a Long Journey.
    Tammemägi MC
    Radiology; 2021 Aug; 300(2):448-449. PubMed ID: 34003060
    [No Abstract]   [Full Text] [Related]  

  • 31. Improving cancer screening programs.
    Kalager M; Bretthauer M
    Science; 2020 Jan; 367(6474):143-144. PubMed ID: 31919207
    [No Abstract]   [Full Text] [Related]  

  • 32. Introduction.
    Eggert JA; Loud JT
    Semin Oncol Nurs; 2017 May; 33(2):119-120. PubMed ID: 28343839
    [No Abstract]   [Full Text] [Related]  

  • 33. Response to "comentary: lung cancer screening--progress or peril.
    McMahon PM; Gazelle SG
    Oncologist; 2008 Jun; 13(6):733. PubMed ID: 18649407
    [No Abstract]   [Full Text] [Related]  

  • 34. [Innovative Cancer Therapeutics Propelled by Model Organisms: Paradigm Shift in Drug Discovery and Diagnosis for Cancer].
    Sugiura R
    Yakugaku Zasshi; 2019; 139(5):731-732. PubMed ID: 31061342
    [No Abstract]   [Full Text] [Related]  

  • 35. Late detection of lung cancer.
    Burki TK
    Lancet Oncol; 2014 Dec; 15(13):e590. PubMed ID: 25499289
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening for lung cancer.
    Eddy DM
    Ann Intern Med; 1990 Jan; 112(1):73-4. PubMed ID: 2403475
    [No Abstract]   [Full Text] [Related]  

  • 37. Lung Cancer Screening and Careful Science-Yes to Both!
    Detterbeck FC
    Ann Thorac Surg; 2023 Apr; 115(4):834. PubMed ID: 36521528
    [No Abstract]   [Full Text] [Related]  

  • 38. Deferral and Resumption of Lung Cancer Screening After COVID-19 Surge: Patient Perspectives From Two Institutions.
    Byrne SC; Jacobson FL; Hammer MM; Dyer DS
    J Am Coll Radiol; 2021 Apr; 18(4):601-604. PubMed ID: 33197408
    [No Abstract]   [Full Text] [Related]  

  • 39. Twenty-year Progress in Lung Cancer Screening: A Marathon, Not a Sprint.
    Sequist LV; Olazagasti C
    Radiology; 2023 Nov; 309(2):e232850. PubMed ID: 37934096
    [No Abstract]   [Full Text] [Related]  

  • 40. A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
    Zhang M; Sun L; Ru Y; Zhang S; Miao J; Guo P; Lv J; Guo F; Liu B
    Int J Mol Med; 2020 Jul; 46(1):252-264. PubMed ID: 32377703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.